Cellular and molecular biology of HCV infection and hepatitis.
about
A new insight into hepatitis C vaccine developmentRecruitment and activation of a lipid kinase by hepatitis C virus NS5A is essential for integrity of the membranous replication compartmentHepatitis C genotype 4: The past, present, and futureDendritic cell-based immunity and vaccination against hepatitis C virus infectionNew hepatitis C virus drug discovery strategies and model systemsDrug-drug interactions during antiviral therapy for chronic hepatitis CThe modulation of apoptosis by oncogenic virusesModulation of paraoxonases during infectious diseases and its potential impact on atherosclerosisInhibition of hepatitis C virus by an M1GS ribozyme derived from the catalytic RNA subunit of Escherichia coli RNase PCell-cell contact-mediated hepatitis C virus (HCV) transfer, productive infection, and replication and their requirement for HCV receptors.Frontiers in the treatment of hepatitis C virus infection.Simultaneous reduction and digestion of proteins with disulfide bonds for hydrogen/deuterium exchange monitored by mass spectrometry.Reversal, maintenance or progression: what happens to the liver after a virologic cure of hepatitis C?Update on different aspects of HCV variability: focus on NS5B polymerase.Direct-acting antiviral agents for hepatitis C virus infection.Human viruses and cancer.Computational study on the molecular mechanisms of drug resistance of Narlaprevir due to V36M, R155K, V36M+R155K, T54A, and A156T mutations of HCV NS3/4A protease.IL-1β production through the NLRP3 inflammasome by hepatic macrophages links hepatitis C virus infection with liver inflammation and diseaseInhibition of HCV replication by oxysterol-binding protein-related protein 4 (ORP4) through interaction with HCV NS5B and alteration of lipid droplet formationBidirectional lipid droplet velocities are controlled by differential binding strengths of HCV core DII protein.Matrix conditions and KLF2-dependent induction of heme oxygenase-1 modulate inhibition of HCV replication by fluvastatin.Identification of ionotrophic purinergic receptors in Huh-7 cells and their response towards structural proteins of HCV genotype 3a.Aberrant transcription and post-transcriptional processing of hepatitis C virus non-structural genes in transgenic mice.New developments in small molecular compounds for anti-hepatitis C virus (HCV) therapy.Interaction of human tumor viruses with host cell surface receptors and cell entryThe impact of IL28B genotype on the gene expression profile of patients with chronic hepatitis C treated with pegylated interferon alpha and ribavirinA Novel Adeno-Associated Virus-Based Genetic Vaccine Encoding the Hepatitis C Virus NS3/4 Protein Exhibits Immunogenic Properties in Mice Superior to Those of an NS3-Protein-Based Vaccine.Metabolic disorders and steatosis in patients with chronic hepatitis C: metabolic strategies for antiviral treatments.Antiviral therapy for hepatitis C virus: beyond the standard of care.Suppression of viral RNA binding and the assembly of infectious hepatitis C virus particles in vitro by cyclophilin inhibitors.RNase P-Mediated Sequence-Specific Cleavage of RNA by Engineered External Guide SequencesAn insight into the molecular characteristics of hepatitis C virus for clinicians.Perinatal transmission of hepatitis C antigens: envelope 1, envelope 2 and non-structural 4.Cloning and expression of NS3 helicase fragment of hepatitis C virus and the study of its immunoreactivity in HCV infected patients.Inactivation of hepatitis C virus infectivity by human breast milk.Turmeric curcumin inhibits entry of all hepatitis C virus genotypes into human liver cells.Charge neutralization as the major factor for the assembly of nucleocapsid-like particles from C-terminal truncated hepatitis C virus core protein.Low oxygen tension enhances hepatitis C virus replication.In-cell selectivity profiling of membrane-anchored and replicase-associated hepatitis C virus NS3-4A protease reveals a common, stringent substrate recognition profile.Functional evaluation of synthetic flavonoids and chalcones for potential antiviral and anticancer properties.
P2860
Q21296858-18DD52B5-677E-4F41-8522-6FE1BFCCA740Q24337128-AC72E932-A5AF-4469-A5E2-4C8123D92F32Q26775815-211EFE8D-2C1C-4ED2-9941-206F26EAAF27Q26828003-B830D6D2-799B-4AB0-9BD5-4D65CBCD20DDQ26851159-88B67132-2BE9-4642-AB3A-E1BE6EC87A79Q26864887-9596B7B8-413B-4FB2-B05D-7ECA97C6FDFBQ26995410-8BE7ABA9-146F-42CB-BBA0-AAEE479DDA1AQ27004131-1DC03204-E93E-4D81-B174-F8676983D4BBQ28659084-14DB0D8B-F97E-4D1C-A4F0-5F87A5850D3CQ30541731-13173FC9-C3D0-4937-8781-08A1447E9940Q33571517-E7CA8F0F-F17B-473C-BE20-0AFDEE59ED76Q33673223-18E6FBFB-3160-4CB4-89F9-67FEC22B2E0BQ33731308-4C9656AD-8133-4BF4-9B2F-967FA430854AQ34163394-8555B445-72E3-4D3A-9FDB-299B1F89A906Q34321440-369F8017-7A38-4CD1-B196-04A672E61B13Q34423461-BF072550-9E84-4451-9682-D6AA4BDC13EFQ34436352-D0D021CE-6139-4456-A06D-ACF90AD69A82Q34697945-8189BDEA-0F43-4348-A6D0-232874F9A6D9Q34999693-8C052108-9AB2-40CA-B0F4-AE29B730BC20Q35040770-6D5FABCD-A199-4919-A262-79C8B68F1893Q35163716-04EC9F12-1A66-42DA-B6CE-15D86442EE50Q35225996-30B2D8F9-2CEF-4131-9320-B679054DFC7BQ35284899-95C6BF99-EDD0-4D2A-B665-0A12F0714E1CQ35653358-E58710F4-3815-451F-BBD9-746AE047B71BQ35676027-DA4E7F3F-5048-4588-AD3A-52FDAA1AB7B4Q35812034-25A65DEB-A9B7-478A-94EA-E09CEBAA3AA3Q35837765-E1732958-38CE-417D-ACEC-FBE442653C25Q36026554-04F5626B-9BCC-4D5E-8239-FAC6A9BD2505Q37945201-D7A1A2EA-D7EC-4331-88AA-9821997BA6B3Q38321799-F4779F76-2569-4A67-8DDA-29F621AB205FQ38633823-C5F7F982-DD48-4088-A520-875B327C6FE6Q38825949-F886EFA9-EE99-4D8A-9C53-077328218A2AQ39013016-33838216-EBA0-4650-8993-B778934B62B4Q39025058-F95B5F24-8D5F-41ED-8D7B-C3292B586433Q39091690-859BF435-5AC3-46B5-BBF2-645666AC1237Q39117420-4688DDA7-3451-4D48-AEB1-1A03CFEBC1BDQ39169949-BC26B209-49CE-4CB2-A035-1593B00D8051Q39220382-9EE10E99-73BA-4743-BE36-310322307BD3Q39508229-4BB25932-2DC9-4D3B-A098-0FB40E42575BQ40228338-58FBFF6C-A61A-4A51-A59E-A74B5FBB3FC2
P2860
Cellular and molecular biology of HCV infection and hepatitis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cellular and molecular biology of HCV infection and hepatitis.
@en
Cellular and molecular biology of HCV infection and hepatitis.
@nl
type
label
Cellular and molecular biology of HCV infection and hepatitis.
@en
Cellular and molecular biology of HCV infection and hepatitis.
@nl
prefLabel
Cellular and molecular biology of HCV infection and hepatitis.
@en
Cellular and molecular biology of HCV infection and hepatitis.
@nl
P2860
P356
P1433
P1476
Cellular and molecular biology of HCV infection and hepatitis.
@en
P2093
Hengli Tang
Henry Grisé
P2860
P356
10.1042/CS20080631
P407
P50
P577
2009-06-15T00:00:00Z